USFDA Med Dev Guidance: Premarket Notification (510(k)) Submissions - Dental Composite Resin Devices & Dental Curing Lights
Dental restorative materials and curing devices are important components of modern dentistry, and their safety and performance must be demonstrated before marketing. The U.S. Food and Drug Administration (FDA) has issued guidance documents describing recommendations for premarket notification (510(k)) submissions for dental composite resin devices and dental curing lights.
The two guidance documents provide device-specific recommendations covering device description, predicate comparison, labeling, biocompatibility, performance testing, and other information relevant to 510(k) submissions. Together, they provide manufacturers with a structured approach for preparing submissions for these dental devices.
The Dental Composite Resin Devices – Premarket Notification (510(k)) Submissions guidance applies to dental composite resins used to fill and restore defects or carious lesions in teeth. It covers applicable devices regulated under 21 CFR 872.3690 and 21 CFR 872.3765, including relevant tooth shade resin materials and pit and fissure sealants and conditioners.
The guidance does not cover resin restoratives intended for other uses, such as cementing, coating, fixation, or temporary restoration.
Device Description and Predicate Comparison
FDA recommends providing a complete description of the dental composite resin, including its formulation, components, accessories, and principle of operation.
For each formulation, applicants should provide the complete chemical composition, including polymers, monomers, initiators, curing agents, stabilizers, plasticizers, fillers, colorants, and other additives. The composition should be quantified by percentage mass, with the total accounting for 100%.
The submission should also include labeled images or illustrations of components and accessories and identify the 510(k) status of applicable accessory devices.
A side-by-side comparison with a legally marketed predicate device should address relevant characteristics such as indications for use, principle of operation, materials, compressive and flexural strength, depth of cure, hardness, water absorption, water solubility, and other applicable characteristics.
Labeling, Shelf Life, and Biocompatibility
Proposed labeling should clearly describe the dental composite resin, its intended use, and directions for use. Where applicable, instructions should include information such as curing light intensity and wavelength, curing times, depth of cure, radiopacity, working time, and setting time.
Shelf-life studies should demonstrate that critical device properties remain acceptable throughout the proposed shelf life. For accelerated aging, applicants should provide the aging conditions and rationale supporting their use. Real-time aged samples should also be tested to confirm accelerated-aging results.
Biocompatibility should be evaluated for patient-contacting materials. Relevant endpoints may include cytotoxicity, sensitization, irritation or intracutaneous reactivity, acute systemic toxicity, subacute/subchronic toxicity, and genotoxicity, as applicable.
Non-Clinical Performance Testing
FDA recommends non-clinical performance testing to demonstrate the performance of the device and support substantial equivalence.
Material characterization should identify chemical substances in the formulation and, where applicable, assess the release of substances such as fluoride, calcium, phosphorus, or nitrate ions over time.
Physical and mechanical testing may include flexural strength, water absorption, water solubility, compressive strength, elastic modulus, and surface hardness. Applicable FDA-recognized consensus standards should be considered.
For photoinitiated resins, testing should characterize the energy required for curing, including light intensity, wavelength, curing time for applicable shades, and depth of cure. For self-curing resins, working and setting times should be evaluated.
Radiopacity should also be characterized because adequate radiopacity allows dental restorations to be visualized on radiographs.
Clinical Performance and Device Modifications
Clinical evidence is generally not necessary for most dental composite resin devices. However, FDA may request clinical testing when manufacturers make claims concerning enhanced clinical outcomes, such as improved longevity, tooth remineralization, or reduced decay.
When clinical studies are conducted, applicable requirements for investigational device studies and protection of human subjects should be considered.
For modifications to an existing device, a new 510(k) may be necessary when a change could significantly affect safety or effectiveness or represents a major change in intended use.
The Dental Curing Lights – Premarket Notification (510(k)) Submissions guidance applies to dental curing lights that emit non-ionizing optical radiation intended to photopolymerize dental restorative resins.
It covers applicable devices regulated under 21 CFR 872.6070 and product code EBZ, including broad-beam and monochromatic light sources. Certain laser polymerization devices and devices intended exclusively for tooth bleaching are outside the scope.
Device Description and Predicate Comparison
FDA recommends a complete description of the curing light, including components, patient-contacting materials, accessories, and operating features.
Submissions should include labeled images and descriptions of accessories such as radiometers, filters, shields, light guides, and protective glasses, together with appropriate engineering drawings or schematics.
Applicants should describe the power source, battery and electrical characteristics, light source, wattage, operating modes, controls, sensors, and alarms.
Predicate comparisons should address indications for use, operating modes, light and power sources, accessories, maximum light intensity, radiant power output, peak wavelength, radiant exposure, and patient-contacting materials.
Labeling, Reprocessing, and Biocompatibility
Labeling should provide the intended use and operating instructions, including radiant power output, maximum irradiance, peak wavelength, radiant exposure, recommended distance and angle from the tooth surface, and protective equipment requirements.
Instructions should also explain how to check irradiance output and include appropriate thermal hazard warnings.
For reusable components, cleaning, disinfection, and sterilization instructions should be provided. Biocompatibility evaluation should address applicable endpoints such as cytotoxicity, sensitization, and irritation or intracutaneous reactivity.
Software, Cybersecurity, and Electrical Safety
Where software or firmware controls device operation or output, appropriate software documentation and testing should be included. FDA generally considers software functions for these devices to require a Basic Documentation Level, although certain characteristics may require an Enhanced Documentation Level.
If the device meets the definition of a cyber device, applicable cybersecurity documentation should also be provided.
Dental curing lights should be evaluated for electrical safety and electromagnetic compatibility. Wireless technologies such as Bluetooth, Wi-Fi, or RFID may require additional testing.
Comments